HomepageGRAL • NASDAQ
add
Grail Inc
$Â 35,20
Na sluitingstijd:(1,56%)+0,55
$Â 35,75
Gesloten: 9 mei, 20:00:00 GMT-4 · USD · NASDAQ · Disclaimer
Vorige slotkoers
$Â 36,10
Dag-range
$Â 34,99 - $Â 37,23
Jaar-range
$Â 12,33 - $Â 63,99
Beurswaarde
1,24Â mld. USD
Gem. volume
1,23Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 38,25Â mln. | 26,14% |
Bedrijfskosten | -911,00K | -101,57% |
Netto inkomsten | -97,07Â mln. | 48,24% |
Netto winstmarge | -253,75 | 58,96% |
Winst per aandeel | — | — |
EBITDA | -76,03Â mln. | 44,64% |
Effectief belastingtarief | 23,57% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 763,47Â mln. | 684,76% |
Totale activa | 2,98Â mld. | -23,77% |
Totale passiva | 479,90Â mln. | 79,32% |
Totaal aandelenvermogen | 2,50 mld. | — |
Uitstaande aandelen | 33,90 mln. | — |
Koers-boekwaardeverhouding | 0,49 | — |
Rendement op activa | -9,46% | — |
Rendement op kapitaal | -11,04% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -97,07Â mln. | 48,24% |
Operationele kasstroom | -93,49Â mln. | 27,47% |
Kasstroom uit beleggingen | -546,11Â mln. | -13.920,69% |
Kasstroom uit financiering | 0,00 | -100,00% |
Nettomutatie in liquide middelen | -639,89Â mln. | -1.274,59% |
Vrije kasstroom | 17,03 mln. | — |
Over
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
Grail was spun-out from Illumina on June 24, 2024.
Their liquid biopsy was launched in June 2021 and is called the Galleri test. Promoted as groundbreaking, the test performed poorly in testing and Grail has subsequently faced discontent and legal action from investors claiming they have been misled about the test's potential. Wikipedia
Opgericht
2015
Hoofdvestiging
Website
Werknemers
1.000
